Remko Schotte

2.7k citations

23 papers · 1.8k indexed · 1 hit paper · h-index 14

Co-authors: Hergen Spits Maho Nagasawa Bianca Blom Ton N. Schumacher Sjoerd H. van der Burg Els M.E. Verdegaal Marit M. van Buuren John B.A.G. Haanen
Topics: Immunotherapy and Immune Responses (14 papers)T-cell and B-cell Immunology (11 papers)Immune Cell Function and Interaction (11 papers)
Cited by: Immunology Oncology Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Nature Medicine
Partner nations: Netherlands United Kingdom France

In The Last Decade

Remko Schotte

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

2014 527 citations Carsten Linnemann, Marit M. van Buuren et al. Nature Medicine profile →

Peers

Countries citing papers authored by Remko Schotte

Since Specialization

Citations

This map shows the geographic impact of Remko Schotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remko Schotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remko Schotte more than expected).

Fields of papers citing papers by Remko Schotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remko Schotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remko Schotte. The network helps show where Remko Schotte may publish in the future.

Co-authorship network of co-authors of Remko Schotte

This figure shows the co-authorship network connecting the top 25 collaborators of Remko Schotte. A scholar is included among the top collaborators of Remko Schotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remko Schotte. Remko Schotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	17P KBA1413: An antibody derived from a cured AML patient, recognizes a unique glycoepitope shared by AML, MDS and several solid cancer cells 2025 ·ESMO Open ·Martijn Kedde,Vanessa Clerico Mosina,Bradley R. Pieters,(unknown),(unknown),(unknown),Remko Schotte,Arjen Q. Bakker,Rob C. Roovers,Michael Koslowski,(unknown)	1
2	580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection 2020 ·Annals of Oncology ·Remko Schotte,Julien Villaudy,Martijn Kedde,Wouter Pos,Koen Wagner,(unknown),(unknown),Gemma Moiset,Etsuko Yasuda,(unknown),(unknown),(unknown),Pauline M. van Helden,Els M.E. Verdegaal,Hans van Eenennaam,Sjoerd H. van der Burg,Hergen Spits	1
3	Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo 2020 ·Cancer Immunology Immunotherapy ·(unknown),(unknown),Martijn Kedde,Els M.E. Verdegaal,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Etsuko Yasuda,(unknown),Arjen Q. Bakker,Sjoerd H. van der Burg,Remko Schotte,Julien Villaudy,Hergen Spits,Mette D. Hazenberg,Pauline M. van Helden,Kay‐Uwe Wagner	9
4	582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL 2020 ·Annals of Oncology ·Julien Villaudy,Remko Schotte,(unknown),(unknown),Wouter Pos,(unknown),Etsuko Yasuda,(unknown),Anikó Szabó,(unknown),Martijn Kedde,(unknown),Els M.E. Verdegaal,Pauline M. van Helden,Sjoerd H. van der Burg,Anita W. Rijneveld,Piet Gros,Hergen Spits,Mette D. Hazenberg,Hans van Eenennaam	3
5	14 A patient derived antibody targeting the tetraspanin CD9 inhibits tumour progression and metastasis 2018 ·ESMO Open ·Remko Schotte,Julien Villaudy,Els M.E. Verdegaal,(unknown),(unknown),(unknown),Pauline M. van Helden,Sjoerd van der Burg,Hergen Spits,Wouter Pos	1
6	Neoantigen landscape dynamics during human melanoma–T cell interactions 2016 ·Nature ·Els M.E. Verdegaal,Noel F.C.C. de Miranda,Marten Visser,Tom J. Harryvan,Marit M. van Buuren,Rikke Andersen,Sine Reker Hadrup,Caroline E. van der Minne,Remko Schotte,Hergen Spits,John B.A.G. Haanen,Ellen Kapiteijn,Ton N. Schumacher,Sjoerd H. van der Burg	339
7	High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma (vol 21, pg 81, 2015) 2016 ·Pure Amsterdam UMC ·Carsten Linnemann,Marit M. van Buuren,Laura Bies,Els M.E. Verdegaal,Remko Schotte,Jorg J. A. Calis,Sam Behjati,Arno Velds,Henk Hilkmann,Dris El Atmioui,Marten Visser,Michael R. Stratton,John B.A.G. Haanen,Hergen Spits,Sjoerd H. van der Burg,Ton N. Schumacher	0
8	Critical assessment of human antibody generation in humanized mouse models 2014 ·Journal of Immunological Methods ·Julien Villaudy,Remko Schotte,Nicolas Legrand,Hergen Spits	25
9	High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanomabreakdown → 2014 ·Nature Medicine ·Carsten Linnemann,Marit M. van Buuren,Laura Bies,Els M.E. Verdegaal,Remko Schotte,Jorg J. A. Calis,Sam Behjati,Arno Velds,Henk Hilkmann,Dris El Atmioui,Marten Visser,Michael R. Stratton,John B.A.G. Haanen,Hergen Spits,Sjoerd H. van der Burg,Ton N. Schumacher	527
10	Prospects and Limitations of T Cell Receptor Gene Therapy 2011 ·Current Gene Therapy ·Annelies Jorritsma,Remko Schotte,Miriam Coccoris,Moniek A. de Witte,Ton N. Schumacher	29
11	Synergy between IL-15 and Id2 Promotes the Expansion of Human NK Progenitor Cells, Which Can Be Counteracted by the E Protein HEB Required To Drive T Cell Development 2010 ·The Journal of Immunology ·Remko Schotte,Wendy Dontje,Maho Nagasawa,Yuko Yasuda,Arjen Q. Bakker,Hergen Spits,Bianca Blom	35
12	Isolation and In Vitro Generation of Gene-Manipulated Human Plasmacytoid and Conventional Dendritic Cells 2009 ·Methods in molecular biology ·Remko Schotte,Heike Schmidlin,Maho Nagasawa,Wendy Dontje,Julien J. Karrich,Christel H. Uíttenbogaart,Hergen Spits,Bianca Blom	6
13	Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix‐loop‐helix factor E2‐2 and the Ets factor Spi‐B 2008 ·European Journal of Immunology ·Maho Nagasawa,Heike Schmidlin,Mark G. Hazekamp,Remko Schotte,Bianca Blom	118
14	Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression 2008 ·Blood ·Heike Schmidlin,Sean A. Diehl,Maho Nagasawa,Ferenc A. Scheeren,Remko Schotte,Christel H. Uíttenbogaart,Hergen Spits,Bianca Blom	58
15	Functional Human Antigen-Specific T Cells Produced In Vitro Using Retroviral T Cell Receptor Transfer into Hematopoietic Progenitors 2007 ·The Journal of Immunology ·Anja U. van Lent,Maho Nagasawa,Marleen M. van Loenen,Remko Schotte,Ton N. Schumacher,Mirjam H.M. Heemskerk,Hergen Spits,Nicolas Legrand	38
16	STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression 2005 ·Nature Immunology ·Ferenc A. Scheeren,Marianne Naspetti,Sean A. Diehl,Remko Schotte,Maho Nagasawa,Erwin Wijnands,Ramón Gimeno,Florry A. Vyth‐Dreese,Bianca Blom,Hergen Spits	127
17	Delta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B 2005 ·Blood ·Wendy Dontje,Remko Schotte,Tom Cupedo,Maho Nagasawa,Ferenc A. Scheeren,Ramón Gimeno,Hergen Spits,Bianca Blom	80
18	The ETS Transcription Factor Spi-B Is Required for Human Plasmacytoid Dendritic Cell Development 2004 ·The Journal of Experimental Medicine ·Remko Schotte,Maho Nagasawa,Kees Weijer,Hergen Spits,Bianca Blom	139
19	The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development 2003 ·Blood ·Remko Schotte,Marie‐Clotilde Rissoan,Nathalie Bendriss‐Vermare,Jean‐Michel Bridon,Thomas Duhen,Kees Weijer,Francine Brière,Hergen Spits	94
20	Developmental origin of pre-DC2 2002 ·Human Immunology ·Bianca Blom,(unknown),Remko Schotte,Hergen Spits	19

About Remko Schotte

Remko Schotte is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (11 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (923 citations) and Molecular Biology (468 citations). Remko Schotte has collaborated with scholars based in Netherlands, United Kingdom and France. Frequent co-authors include Hergen Spits, Maho Nagasawa, Bianca Blom, Ton N. Schumacher, Sjoerd H. van der Burg, Els M.E. Verdegaal, Marit M. van Buuren, John B.A.G. Haanen, Marten Visser and Kees Weijer. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact